NCT00004736View on ClinicalTrials.gov

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

Not specified

Conditions
HIV InfectionsTuberculosis
Interventions
DRUG

Nelfinavir mesylate

DRUG

Ethambutol hydrochloride

DRUG

Isoniazid

DRUG

Pyrazinamide

DRUG

Lamivudine

DRUG

Rifabutin

DRUG

Stavudine

DRUG

Zidovudine

Trial Locations (10)

10003

Beth Israel Med Ctr, New York

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10032

Columbia Presbyterian Med Ctr, New York

19104

Univ of Pennsylvania at Philadelphia, Philadelphia

37203

Vanderbilt Univ Med Ctr, Nashville

60612

Cook County Hosp, Chicago

900331079

Univ of Southern California / LA County USC Med Ctr, Los Angeles

921036325

Univ of California / San Diego Treatment Ctr, San Diego

02906

Brown Univ / Miriam Hosp, Providence

Miriam Hosp / Brown Univ, Providence

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00004736 - Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis | Biotech Hunter | Biotech Hunter